Effects of a new oral hypoglycaemic agen
β
B. H. R. Wolffenbuttel; L. Nijst; J. P. J. E. Sels; P. P. C. A. Menheere; P. G.
π
Article
π
1993
π
Springer
π
English
β 396 KB
We have evaluated the effects of repaglinide, a new non-sulphonylurea oral hypoglycaemic agent that has a stimulatory effect on insulin secretion. Forty-four patients with NIDDM, already treated with a sulphonylurea, took part in an open, randomised, group comparison study of 12 weeks duration, duri